Trial Profile
A multicenter clinical trial of the effect of raloxifene hydrochloride for the prevention of health care problems caused by bilateral oophorectomy due to endometrial cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Raloxifene (Primary) ; Alfacalcidol; Calcium
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 30 May 2014 Final results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 10 Mar 2014 New trial record